155 related articles for article (PubMed ID: 35220069)
1. Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium.
Allehebi A; Kattan KA; Rujaib MA; Dayel FA; Black E; Mahrous M; AlNassar M; Hussaini HA; Twairgi AA; Abdelhafeiz N; Omair AA; Shehri SA; Al-Shamsi HO; Jazieh AR
Cancer Treat Res Commun; 2022; 31():100538. PubMed ID: 35220069
[TBL] [Abstract][Full Text] [Related]
2. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
3. Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations.
Göker E; Altwairgi A; Al-Omair A; Tfayli A; Black E; Elsayed H; Selek U; Koegelenberg C
Lung Cancer; 2021 Aug; 158():60-73. PubMed ID: 34119934
[TBL] [Abstract][Full Text] [Related]
4. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Daly ME; Singh N; Ismaila N; Antonoff MB; Arenberg DA; Bradley J; David E; Detterbeck F; Früh M; Gubens MA; Moore AC; Padda SK; Patel JD; Phillips T; Qin A; Robinson C; Simone CB
J Clin Oncol; 2022 Apr; 40(12):1356-1384. PubMed ID: 34936470
[TBL] [Abstract][Full Text] [Related]
5. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
6. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC;
Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.
Majem M; Hernández-Hernández J; Hernando-Trancho F; Rodríguez de Dios N; Sotoca A; Trujillo-Reyes JC; Vollmer I; Delgado-Bolton R; Provencio M
Clin Transl Oncol; 2020 Jan; 22(1):21-36. PubMed ID: 31172444
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement.
Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A
Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
10. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
11. Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline.
Moeller B; Balagamwala EH; Chen A; Creach KM; Giaccone G; Koshy M; Zaky S; Rodrigues G
Pract Radiat Oncol; 2018; 8(4):245-250. PubMed ID: 29625898
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
[TBL] [Abstract][Full Text] [Related]
13. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
Brahmer JR; Govindan R; Anders RA; Antonia SJ; Sagorsky S; Davies MJ; Dubinett SM; Ferris A; Gandhi L; Garon EB; Hellmann MD; Hirsch FR; Malik S; Neal JW; Papadimitrakopoulou VA; Rimm DL; Schwartz LH; Sepesi B; Yeap BY; Rizvi NA; Herbst RS
J Immunother Cancer; 2018 Jul; 6(1):75. PubMed ID: 30012210
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM
J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810
[TBL] [Abstract][Full Text] [Related]
15. Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.
Tankel J; Spicer J; Chu Q; Fiset PO; Kidane B; Leighl NB; Joubert P; Maziak D; Palma D; McGuire A; Melosky B; Snow S; Bahig H; Blais N
Curr Oncol; 2023 Dec; 30(12):10363-10384. PubMed ID: 38132389
[TBL] [Abstract][Full Text] [Related]
16. Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC.
Tan WL; Chua KLM; Lin CC; Lee VHF; Tho LM; Chan AW; Ho GF; Reungwetwattana T; Yang JC; Kim DW; Soo RA; Ahn YC; Onishi H; Ahn MJ; Mok TSK; Tan DSW; Yang F
J Thorac Oncol; 2020 Mar; 15(3):324-343. PubMed ID: 31733357
[TBL] [Abstract][Full Text] [Related]
17. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Passaro A; Leighl N; Blackhall F; Popat S; Kerr K; Ahn MJ; Arcila ME; Arrieta O; Planchard D; de Marinis F; Dingemans AM; Dziadziuszko R; Faivre-Finn C; Feldman J; Felip E; Curigliano G; Herbst R; Jänne PA; John T; Mitsudomi T; Mok T; Normanno N; Paz-Ares L; Ramalingam S; Sequist L; Vansteenkiste J; Wistuba II; Wolf J; Wu YL; Yang SR; Yang JCH; Yatabe Y; Pentheroudakis G; Peters S
Ann Oncol; 2022 May; 33(5):466-487. PubMed ID: 35176458
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
19. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC.
Batra U; Munshi A; Kabra V; Momi G
Indian J Cancer; 2022 Mar; 59(Supplement):S46-S55. PubMed ID: 35343190
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.
Rodrigues G; Choy H; Bradley J; Rosenzweig KE; Bogart J; Curran WJ; Gore E; Langer C; Louie AV; Lutz S; Machtay M; Puri V; Werner-Wasik M; Videtic GMM
Pract Radiat Oncol; 2015; 5(3):149-155. PubMed ID: 25957185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
